PharMerica selected by Teva Pharmaceuticals to dispense AUSTEDO™

On April 3, 2017, the U.S. Food and Drug Administration approved AUSTEDO™ (deutetrabenazine), manufactured by Teva Pharmaceuticals. AUSTEDO™ is indicated for the treatment of chorea associated with Huntington’s Disease.

Teva Pharmaceuticals has elected to distribute AUSTEDO™ through three select pharmacies. PharMerica is pleased to inform you that it has been selected by Teva Pharmaceuticals as one of those pharmacies.

AUSTEDO™ has been clinically shown to decrease the Total Maximal Chorea Score in patients by 4.4 points based on the Unified Huntington’s Disease Rating Scale (UHDRS).

AUSTEDO™ has a Black Box Warning for DEPRESSION AND SUICIDALITY, for increasing the risk of depression and suicidal thoughts and behavior. Balance risks of depression and suicidality with the clinical need for treatment of chorea when considering the use of AUSTEDO™.

Please enter the following information for more details.

About Huntington's Disease

Huntington’s Disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability (cognition).

Adult onset Huntington’s Disease, the most common form of this disorder, usually appears in a person’s thirties or forties. Early signs and symptoms can include irritability, depression, small involuntary movements, poor coordination, and trouble learning new information or making decisions. Many people with Huntington’s Disease develop involuntary jerking or twitching movements known as chorea. As the disease progresses, these movements become more pronounced. Affected individuals may have trouble walking, speaking, and swallowing. People with this disorder also experience changes in personality and a decline in thinking and reasoning abilities. Individuals with the adult onset form of Huntington’s Disease usually live about 15 to 20 years after signs and symptoms begin.

Source: US National Library of Medicine

If your facility is presently treating any resident diagnosed with Huntington’s Disease and their attending physician desires to prescribe them AUSTEDO™, PharMerica is ready to assist your facility secure this medication for your resident. We look forward to helping you.

To order an AUSTEDO™ prescription please
contact PharMerica at 1-800-678-7575 press
option #1, ext. #855421 or #855403

Click below to view our Special Edition InformRx Newsletter.

PharM InformRx Special Ed June 2017

Please enter the following information and the info sheet will be immediately provided to you.